Anuradha Mascarenhas discusses the new management guidelines for treating Covid-19 in children and teenagers, including the use of antivirals and monoclonal antibodies, as well as mask suggestions.Regardless of the degree of infection, the Health Ministry’s updated guidelines for managing Covid-19 in children and teenagers under the age of 18 advise against using antivirals or monoclonal antibodies.
According to the recommendations, children under the age of five should not wear masks.The revised standards, which went into effect on January 20, 2021, supplant the prior version, which expired on June 16, 2021.
A committee of specialists examined the Comprehensive Guidelines for Management of COVID-19 in Children and Teens Under the Age of 18 in light of the current outbreak, which is mostly related to the Omicron variant of concern. The existing evidence from other nations suggests that the Omicron form causes less severe illness; yet, as the present wave progresses, it is necessary to keep a close eye on it.
According to the Union Ministry of Health and Family Welfare, these guidelines are dynamic and will be evaluated and revised when new evidence becomes available.
Antivirals and monoclonal antibodies are not indicated for children under the age of 18, regardless of the severity of the infection.
Antimicrobials have no function in the therapy of simple COVID-19 infection since it is a viral illness. Overall, the treatment of children is unchanged.
The most common therapy for temperature is to administer 10-15mg/kg/dose of paracetamol, which can be repeated each 4-6 hours.
In older children and adults with a cough, throat soothing medicines and hot saline gargles have been recommended.
One of the recommendations is to drink enough oral fluids to stay hydrated, as well as eat a healthy diet. Dr. Aarti Kinikar, a member of the Maharashtra paediatric COVID task committee, stated that no further COVID-19 specific drug is required in mild instances.